ACST's CaPre Misses Goal Again, AIMT Snapped Up By Nestle, CRMD To Face FDA In Feb, VIR & COVID-19

Today's Daily Dose brings you news about Acasti Pharma's phase III trial of CaPre, Merger Monday, CorMedix's regulatory catalyst, Vanda Pharma's anticipated milestones, and the progress in Vir/Glaxo's COVID-19 trial.

from RTT - Top Story https://ift.tt/3jAjgkG
via IFTTT